Genocea Biosciences Inc

Ticker GNCA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Cambridge, Massachusetts

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel vaccines and immunotherapies to treat infectious diseases. The company uses its proprietary discovery platform, AnTigen Lead Acquisition System, to design vaccines and immunotherapies that act through T cell immune responses.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (79)

Genocea Biosciences Inc reports have an aggregate usefulness score of 4.8 based on 79 reviews.

Genocea Biosciences Inc

Most Recent Annual Report

MOST RECENT 2021 Form 10K

View Form 10K (HTML)

Genocea Biosciences Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.